AMEX, HEB - Hemispherx Biopharma
We are a biopharmaceutical company engaged in the clinical development,
manufacture, marketing and distribution of new drug therapies based on natural
immune system enhancing technologies for the treatment of viral and immune based
chronic disorders. The Company was founded in the early 1970s doing contract
research for the National Institutes of Health. Since that time, we have
established a strong foundation of laboratory, pre-clinical, and clinical data
with respect to the development of nucleic acids to enhance the natural
antiviral defense system of the human body and to aid the development of
therapeutic products for the treatment of certain chronic diseases. We have
three domestic subsidiaries BioPro Corp., BioAegean Corp., and Core BioTech
Corp., all of which are incorporated in Delaware and are dormant. Our foreign
subsidiaries include Hemispherx Biopharma Europe N.V./S.A. established in
Belgium in 1998 and Hemispherx Biopharma Europe S.A. ...
Read SEC Filing on NASDAQ.com »